Bengt Sylvén

2.6k citations
54 papers · 1.5k indexed · h-index 25
Topics
Peptidase Inhibition and Analysis (8 papers)Cancer, Hypoxia, and Metabolism (6 papers)Enzyme function and inhibition (5 papers)

In The Last Decade

Bengt Sylvén

54 papers receiving 1.2k citations

Peers

Bengt Sylvén
Comparison fields: 5 of 123
  • Molecular Biology 521
  • Cell Biology 275
  • Oncology 251
  • Cancer Research 246
  • Pharmacology 145
Replace G C Easty with:
G C Easty United Kingdom
K. Hellmann United Kingdom
D M Easty United Kingdom
G Gasic United States
Teruhiko Inoue Japan
S. C. Barranco United States
C J Edgell United States
Yuko Ohnuki Japan
G. A. Turner United Kingdom
Takeshi Takahashi Japan
Bengt Sylvén relative to G C Easty United Kingdom G C Easty's profile →
Citations per field
00.5×
G C Easty · 1×
Citations per year

Countries citing papers authored by Bengt Sylvén

Since Specialization
Citations

This map shows the geographic impact of Bengt Sylvén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Sylvén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Sylvén more than expected).

Fields of papers citing papers by Bengt Sylvén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Sylvén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Sylvén. The network helps show where Bengt Sylvén may publish in the future.

Co-authorship network of co-authors of Bengt Sylvén

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Sylvén. A scholar is included among the top collaborators of Bengt Sylvén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Sylvén. Bengt Sylvén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 14
2
Malignant neuroepithelioma in childhood. A report of three cases.
11
3 17
4 63
5 22
6
ON THE CHEMICAL PATHOLOGY OF INTERSTITIAL FLUID. I. PROTEOLYTIC ACTIVITIES IN TRANSPLANTED MOUSE TUMORS.
60
7
Lactic dehydrogenase activity in plasma and interstitial fluid during growth of mouse tumors.
12
8 27
9
Some biochemical factors possibly concerned in the destructiveness of malignant growth.
3
10 21
11
On the interaction between metachromatic dyes and various substrates of biological interest.
20
12 35
13 20
14 17
15 11
16 35
17
Malignant melanoma of the skin.
8
18 39
19
On the alleged metachromasia of hyaluronic acid.
44
20 38

About Bengt Sylvén

Bengt Sylvén is a scholar working on Biotechnology, Cell Biology and Oncology, having authored 54 papers that have together received 1.5k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Enzyme function and inhibition (5 papers). The work is most often cited by research in Cell Biology (275 citations), Cancer Research (246 citations) and Biotechnology (86 citations). Bengt Sylvén has collaborated with scholars based in Sweden, United Kingdom and Switzerland. Frequent co-authors include Olle Snellman, R. J. Goldacre, H. Malmgren, Carl Hirsch, Adel Gad, E A Burgess, David Glick, Robert J. Harris, Bo Holmberg and S. F. D. Orr. Their work appears in journals such as Nature, Science and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026